Back

In vivo BMAL1 occupancy mapping using MACS-Calling Cards reveals disease-associated retargeting in Cln3Δex7/8 astrocytes

Reiss, I. H.; Cooper, J. D.; Musiek, E. S.; Mitra, R. D.

2026-05-05 genomics
10.64898/2026.04.30.721783 bioRxiv
Show abstract

Astrocytic homeostatic programs, many of which are regulated by the circadian clock, are disrupted early in neurodegenerative disease. The core clock transcription factor (TF) BMAL1 is required for normal astrocyte function, but its role during disease remains unclear. This is partly because methods for identifying cell type-specific TF binding sites are limited. Here, we developed MACS-Calling Cards (MACS-CC), a strategy for mapping astrocyte-specific TF occupancy in vivo. We used MACS-CC to define BMAL1 binding in the Cln3{Delta}ex7/8 mouse model of CLN3 disease, a fatal neurodegenerative disorder marked by early astrocyte dysfunction and circadian disruption. BMAL1 binding was extensively redistributed in Cln3{Delta}ex7/8 astrocytes: wild-type-specific binding sites enriched near glial differentiation genes, whereas Cln3{Delta}ex7/8-specific sites lacked functional enrichment. Consistent with these changes, Cln3{Delta}ex7/8 astrocytes decreased expression of mature astrocyte markers. To define mechanisms underlying BMAL1 retargeting, we tested whether altered chromatin accessibility explained the changes in BMAL1 binding. Although chromatin accessibility was broadly remodeled, differential accessibility did not predict BMAL1 redistribution. Instead, motif analysis suggested that loss of cooperative TF interactions drives BMAL1 retargeting. These findings demonstrate that MACS-CC enables astrocyte-specific TF occupancy mapping and reveals mechanisms behind early rewiring of circadian regulatory programs within a model of a neurodegenerative disease. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=80 SRC="FIGDIR/small/721783v2_ufig1.gif" ALT="Figure 1"> View larger version (22K): org.highwire.dtl.DTLVardef@1ada239org.highwire.dtl.DTLVardef@7564a3org.highwire.dtl.DTLVardef@122222forg.highwire.dtl.DTLVardef@1f2729c_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Computational and Structural Biotechnology Journal
216 papers in training set
Top 0.2%
10.1%
2
Scientific Reports
3102 papers in training set
Top 18%
6.4%
3
Glia
74 papers in training set
Top 0.1%
6.3%
4
Cell Reports Methods
141 papers in training set
Top 0.4%
6.3%
5
iScience
1063 papers in training set
Top 3%
4.2%
6
PLOS Genetics
756 papers in training set
Top 4%
3.6%
7
eLife
5422 papers in training set
Top 29%
3.1%
8
Open Biology
95 papers in training set
Top 0.3%
2.6%
9
Life Science Alliance
263 papers in training set
Top 0.1%
2.4%
10
G3 Genes|Genomes|Genetics
351 papers in training set
Top 1.0%
2.1%
11
Molecular Brain
26 papers in training set
Top 0.1%
2.1%
12
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.3%
1.9%
50% of probability mass above
13
Communications Biology
886 papers in training set
Top 8%
1.7%
14
PLOS Biology
408 papers in training set
Top 9%
1.7%
15
Neurobiology of Disease
134 papers in training set
Top 3%
1.7%
16
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.7%
17
Bioinformatics
1061 papers in training set
Top 7%
1.7%
18
Cell Reports
1338 papers in training set
Top 26%
1.5%
19
Frontiers in Genetics
197 papers in training set
Top 5%
1.5%
20
PLOS ONE
4510 papers in training set
Top 58%
1.3%
21
Cell Genomics
162 papers in training set
Top 5%
1.2%
22
Genome Medicine
154 papers in training set
Top 6%
1.2%
23
Translational Psychiatry
219 papers in training set
Top 3%
0.9%
24
Physiological Genomics
15 papers in training set
Top 0.3%
0.9%
25
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
26
Genome Research
409 papers in training set
Top 4%
0.8%
27
The FASEB Journal
175 papers in training set
Top 3%
0.8%
28
BMC Genomics
328 papers in training set
Top 5%
0.8%
29
Epigenetics
43 papers in training set
Top 1.0%
0.7%
30
Aging Cell
144 papers in training set
Top 3%
0.7%